Yixin Yao, PhD¹, Lingzhi Li^1*, Yuxuan Che^1*, Joseph McIntosh, BS^1*, Holly Hill^1*, Yang Liu, PhD^1* and Michael Wang, MD^1,2

¹Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
²Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX

Nataliya A. Petinati, PhD, MD^1*, Nikolay M. Kapranov^2*, Julia O. Davydova^3*, Natalia V. Sats, PhD^4*, Irina Malyants^5*, Victoria Shender, PhD^6*, Georgiy Arapidi, PhD^5*, Maria A. Lagarkova, PhD^6*, Ekaterina A. Fastova, MD^2*, Aminat A. Magomedova, MD, PhD^2*, Sergey K. Kravchenko, MD, PhD^2* and Nina J. Drize, PhD⁴

¹Lab for Physiology of Hematopoiesis, National Research Center for Hematology, Moscow, Russia
²National Research Center for Hematology, Moscow, Russian Federation
³Laboratory of Immunophenotyping of blood and bone marrow cells, National Research Center for Hematology, Moscow, Russian Federation
⁴Lab for Physiology of Hematopoiesis, National Research Center for Hematology, Moscow, Russian Federation
⁵Federal Research and Clinical Center of Physical-Chemical Medicine, Moscow, Russian Federation
⁶Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, Moscow, Russian Federation

Yixin Yao, PhD¹, Yuxuan Che^1*, Yang Liu, PhD^1*, Lingzhi Li^1*, Alexa A Jordan, BS^1*, Preetesh Jain, MBBS, MD, DM, PhD¹ and Michael Wang, MD^1,2

¹Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
²Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX

Catherine Thieblemont, MD, PhD¹, Sylvie Chevret, MD, PhD^2*, Vincent Allain^3*, Roberta Di Blasi^4*, Florence Morin^5*, Laetitia Vercellino^6*, Sandrine Roulland, PhD^7*, Karin Tarte, PhD PharmD⁸, Veronique Meignin^9* and Sophie Caillat-Zucman, MD, PhD^10*

¹Department of Hemato-Oncology, Hôpital Saint-Louis, Assistance Publique – Hôpitaux de Paris, Paris, France
²Division of Biostatistics, Saint-Louis Hospital, GH APHP Nord Université de Paris, Paris, France
³Assistance Publique Des Hopitaux De Paris, Paris, FRA
⁴Hémato-oncologie, Assistance Publique Hôpitaux de Paris - Hopital Saint-Louis, Paris, Paris, France
⁵Hopital Saint Louis, Paris, France
⁶Hôpital Saint Louis, Paris, France
⁷Genomic instability and human hemopathies, Centre d' Immunologie de Marseille - Luminy, Marseille, Cedex 09, France
⁸INSERM, Rennes, France
⁹Hopital Saint-Louis, PARIS, France
¹⁰Laboratory of Immunology, INSERM UMR1149, Saint Louis Hospital, APHP, University of Paris, Paris, France

Yuqin Song, MD, PhD^1*, Quanli Gao, MD^2*, Lei Fan, MD, PhD^3*, Dehui Zou, MD^4*, Huilai Zhang, MD, PhD^5*, Jianfeng Zhou, MD, PhD^6*, Wei Li, MD^7*, Haiyan Yang, MD, PhD^8*, Ting Liu, MD, PhD⁹, Quanshun Wang, MD, PhD^10*, Fangfang Lv, MD^11*, Dan Wang, PhD^12*, Pei Zhang, PhD^13*, Tengfei Liu, PhD^13*, Yun Zhang, PhD^13*, Zhirong Shen, PhD^13*, Lei Wang, PhD^13*, Liudi Yang, MD^12*, Haiyi Guo, MD^13* and Jun Zhu, MD, PhD^1*

¹Department of Lymphoma, Peking University Cancer Hospital & Institute (Beijing Cancer Hospital), Beijing, China
²Department of Immunotherapy, Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, China
³Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing, China
⁴lymphoma and myeloma center, National Clinical Research Center for Blood Diseases, State Key Laboratory of Experimental Hematology, Blood Diseases Hospital & Institute of Hematology, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
⁵Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer, Tianjin, China
⁶Department of Hematology, Tongji Hospital, Tongji Medical College, Wuhan, China
⁷Department of Hematology, Cancer Center, The First Hospital of Jilin University, Changchun, China
⁸Department of Lymphoma, Zhejiang Cancer Hospital, Hangzhou, China
⁹Department of Hematology, West China Hospital of Sichuan University, Chengdu, China
¹⁰Department of Hematology, Chinese PLA General Hospital, Beijing, China
¹¹Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China
¹²BeiGene Co., Ltd., Shanghai, China
¹³BeiGene Co., Ltd., Beijing, China

Jose C Villasboas, MD¹, Patrizia Mondello, MD, PhD, MSc^2,3, Angelo Fama, MD^2,4*, Melissa L. Larson, MD⁵, Andrew L. Feldman, MD⁶, Zhi-Zhang Yang, PhD⁷, Ilia Galkin, MS^8*, Viktor Svekolkin, MS^8*, Ekaterina Postovalova, PhD^8*, Alexander Bagaev, MS^8*, Pavel Ovcharov, MS^8*, Arina Varlamova, MS^8*, Sarah Huet^9*, Bruno Tesson^10*, Kaitlyn R McGrath^11*, Susan L. Slager, PhD¹², Sergei Syrbu, MD, PhD^13*, Anne J. Novak, PhD², Thomas M. Habermann, MD², Thomas E. Witzig, MD², Grzegorz S. Nowakowski, MD¹¹, Gilles Salles^14,15, James R. Cerhan, MD, PhD⁵ and Stephen M. Ansell, MD, PhD¹¹

¹Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN
²Division of Hematology, Mayo Clinic, Rochester, MN
³Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY
⁴Hematology Unit, Arcispedale Santa Maria Nuova, Azienda Unità Sanitaria Locale- IRCCS, Reggio Emilia, Italy
⁵Department of Health Sciences Research, Mayo Clinic, Rochester, MN
⁶Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN
⁷Division of Hematology and Internal Medicine, Mayo Clinic, Rochester, MN
⁸BostonGene, Waltham, MA
⁹Laboratoire d'Hématologie, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, Pierre Bénite, France
¹⁰Institut Carnot CALYM, Pierre BéNite, FRA
¹¹Mayo Clinic, Rochester, MN
¹²Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN
¹³Department of Pathology, University of Iowa, Iowa City, IA
¹⁴Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
¹⁵Hematology Department, Centre Hospitalier Lyon-Sud, Pierre-Bénite, France

Katsuyoshi Takata, MD, PhD^1*, Tomohiro Aoki, MD, PhD^1*, Lauren C. Chong, MSc^1*, Katy Milne^2*, Tomoko Miyata-Takata, MD, PhD^1*, Karanvir Singh^3*, Talia Goodyear^4*, Pedro Farinha, MD, PhD¹, Graham W. Slack, MD⁵, Laurie H. Sehn, MD, MPH⁶, Kerry J. Savage, MD MSc⁷, Brad H Nelson^3*, David W. Scott, MBChB, PhD⁸ and Christian Steidl, MD¹

¹Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada
²Deeley Research Centre, BC Cancer, Vancouver, BC, Canada
³Trev and Joyce Deeley Research Centre, British Columbia Cancer Agency, Victoria, BC, Canada
⁴Department of Biochemistry and Microbiology, University of Victoria, Victoria, BC, Canada
⁵BC Cancer Centre for Lymphoid Cancer and Department of Pathology and Laboratory Medicine, Vancouver, BC, Canada
⁶BC Cancer Centre for Lymphoid Cancer, University of British Columbia, vancouver, BC, Canada
⁷Centre for Lymphoid Cancer, Department of Medical Oncology, BC Cancer and University of British Columbia, Vancouver, BC, Canada
⁸British Columbia Cancer, Vancouver, Canada

Siba El Elhussein, MD^1*, L. Jeffrey Medeiros, MD¹, Kirill A. Lyapichev, MD^1*, Stephen K. Gruschkus, PhD, MPH^2*, Peng Wei, PhD^2*, Ellen Schlette, MD^1*, Warren Fiskus, BSc, PhD³, Rashmi Kanagal-Shamanna, MD⁴, Sanam Loghavi, MD¹, Hong Yang, MD, PhD^1*, Shaoying Li, MD^1*, Jie Xu, MD^1*, Zhenya Tang, MD, PhD^1*, Beenu Thakral, MD^1*, Nitin Jain, MD⁵, William G. Wierda, MD, PhD³, Keyur Patel, MD, PhD^1*, Kapil N. Bhalla, MD³ and Joseph D. Khoury, MD¹

¹Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, TX
²Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, TX
³Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX
⁴Department of Hematopathology, Division of Pathology/Lab Medicine, University of Texas MD Anderson Cancer Center, Houston, TX
⁵Associate Professor of Medicine Department of Leukemia The University of Texas MD Anderson Cancer Center, Houston, TX